Skip to main content
Premium Trial:

Request an Annual Quote

Applera Will Pay Undisclosed Sum to Genetic Technologies to Settle IP-Infringement Suit

NEW YORK, Dec. 12 (GenomeWeb News) - Applera has agreed to pay Genetic Technologies an undisclosed amount to settle their ongoing patent-infringement suit surrounding the firm's junk DNA gene-testing technologies, according to Genetic Technologies.

 

While details of the 18-hour mediation session that resulted in the settlement remain confidential, the companies executed several binding agreements, including a final settlement agreement, a license agreement, and a supply agreement, according to an announcement made to Gene Technologies shareholders today. All claims and counterclaims will be dismissed, the firm said.

 

The technologies on which the case was built represents the only US patent on the use of non-coding DNA markers for gene testing.

 

Genetic Technologies originally sued Applera and two other US companies in March 2003 for not purchasing licenses and paying royalties. The other companies settled separately in November 2004. Applera agreed to pursue further negotiations on Oct. 13 and both sides agreed to a settlement on Dec. 9.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.